To send content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about sending content to .
To send content items to your Kindle, first ensure firstname.lastname@example.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about sending to your Kindle.
Note you can select to send to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Fetal growth restriction (FGR) can be defined as the failure of the fetus to meet its genetically predetermined growth potential  and is associated with significant fetal and perinatal morbidity and mortality. In addition, there is evidence to suggest a longer-term impact of FGR on childhood neurodevelopmental outcomes  and cardiovascular and metabolic diseases that manifest in adulthood . However, predicting FGR is not straightforward and methods for screening and diagnosis are imprecise. In the UK and USA, ultrasound scans in the second half of pregnancy are not performed routinely but targeted at women considered to be at risk for FGR, where high risk is identified by maternal characteristics (including anthropometry and pre-existing disease), the development of complications, or clinical suspicion based on being ‘small for dates’ on physical examination. For practical purposes, FGR may be suspected if biometric measurements are below a given threshold of the distribution in the population, typically <10th, 5th or 3rd centile for gestational age, or if there is a reduction in growth velocity (‘crossing centiles’) from previous scans . The difficulty with using biometry alone is that it does not differentiate between the growth-restricted fetus affected by placental insufficiency, and the healthy, constitutionally small fetus. Therefore, additional measures may be employed to diagnose placental dysfunction, such as Doppler studies of the fetal and uteroplacental circulation, and analysis of maternal serum biomarkers. At present, the only treatment available for FGR is to expedite delivery, but at preterm gestations this can also can cause harm. However, new genomics-based research could help us better understand the etiology of growth restriction and identify more accurate diagnostic biomarkers or potential therapeutic targets. This chapter will focus on current practice in screening for and intervention in FGR and will also consider new developments and the future of the field.
At the time of the discovery of the physiological changes of spiral arteries in the pregnant uterus, Brosens and colleagues suggested that these changes result from the destructive action of the invading trophoblasts on the vascular smooth muscle and the elastic membrane. This chapter reiterates the main findings regarding the successive spiral artery remodeling steps. It seems appropriate to relate the time-course of the vascular remodeling process to the new insights in uteroplacental flow changes during this pregnancy period. In preeclampsia, trophoblast-associated remodeling is restricted to decidual spiral arteries throughout the placental bed. Spiral artery conversion is obviously important for safeguarding an adequate maternal blood supply to the placenta. Deep trophoblast invasion and spiral artery remodeling of the inner 'junctional zone' myometrium is a feature of normal human pregnancy, while in preeclampsia and maybe in other pregnancy complications this process may be seriously impaired.
Psychiatric phenotypes are currently defined according to sets of
descriptive criteria. Although many of these phenotypes are heritable, it
would be useful to know whether any of the various diagnostic categories
in current use identify cases that are particularly helpful for
To use genome-wide genetic association data to explore the relative
genetic utility of seven different descriptive operational diagnostic
categories relevant to bipolar illness within a large UK case–control
bipolar disorder sample.
We analysed our previously published Wellcome Trust Case Control
Consortium (WTCCC) bipolar disorder genome-wide association data-set,
comprising 1868 individuals with bipolar disorder and 2938 controls
genotyped for 276 122 single nucleotide polymorphisms (SNPs) that met
stringent criteria for genotype quality. For each SNP we performed a test
of association (bipolar disorder group v. control group) and used the
number of associated independent SNPs statistically significant at
P<0.00001 as a metric for the overall genetic
signal in the sample. We next compared this metric with that obtained
using each of seven diagnostic subsets of the group with bipolar
disorder: Research Diagnostic Criteria (RDC): bipolar I disorder; manic
disorder; bipolar II disorder; schizoaffective disorder, bipolar type;
DSM–IV: bipolar I disorder; bipolar II disorder; schizoaffective
disorder, bipolar type.
The RDC schizoaffective disorder, bipolar type (v.
controls) stood out from the other diagnostic subsets as having a
significant excess of independent association signals
(P<0.003) compared with that expected in samples of
the same size selected randomly from the total bipolar disorder group
data-set. The strongest association in this subset of participants with
bipolar disorder was at rs4818065 (P = 2.42 ×
10–7). Biological systems implicated included gamma
amniobutyric acid (GABA)A receptors. Genes having at least one
associated polymorphism at P<10–4 included
B3GALTS, A2BP1, GABRB1, AUTS2, BSN, PTPRG, GIRK2 and
Our findings show that individuals with broadly defined bipolar
schizoaffective features have either a particularly strong genetic
contribution or that, as a group, are genetically more homogeneous than
the other phenotypes tested. The results point to the importance of using
diagnostic approaches that recognise this group of individuals. Our
approach can be applied to similar data-sets for other psychiatric and
Early results from the SAGE-SMC (Surveying the Agents of Galaxy Evolution in the tidally-disrupted, low-metallicity Small Magellanic Cloud) Spitzer legacy program are presented. These early results concentrate on the SAGE-SMC MIPS observations of the SMC Tail region. This region is the high H i column density portion of the Magellanic Bridge adjacent to the SMC Wing. We detect infrared dust emission and measure the gas-to-dust ratio in the SMC Tail and find it similar to that of the SMC Body. In addition, we find two embedded cluster regions that are resolved into multiple sources at all MIPS wavelengths.
The immediate clinical consequences and associations of pre-eclampsia are the subject of intense study and are reviewed in depth throughout this volume. It is natural for any woman who experiences a hypertensive disorder in pregnancy to enquire what implications this has, if any, for her future health. While the long-term outcome of women who experience pre-eclampsia has been the subject of research, there are still major uncertainties regarding this area due to the inherent problems of long-term longitudinal clinical studies. The aim of this chapter is to summarize the recent evidence regarding the implications of pre-eclampsia occurring during pregnancy for a woman's health in later life. Moreover, methodological issues related to addressing this research question will also be reviewed both to assist interpretation of the existing literature and to provide guidance for how future studies might be conducted.
Methodological issues in determining long-term associations with pre-eclampsia
Epidemiological studies generally aim to quantify the association between developing a given disease and some characteristic in a population. The characteristic can take many forms, such as a blood test, environmental exposure or socio-economic factor. The first step in any study is to determine whether the outcome and exposure are associated to a degree which is greater than expected by chance. Any analysis assumes that a sufficient number of individuals were studied to allow detection of an association, were any to exist. Having demonstrated an association, the next step is to determine whether the association is likely to be causal.
We evaluated selected cool-season annual and perennial legumes as potential ground covers to supply nitrogen and to increase beneficial arthropod populations in a pecan orchard. Densities of aphids (Homoptera: Aphididae), lady beetles (Coleoptera: Coccinellidae), damsel bug (Hemiptera: Nabidae), green lacewings (Neuroptera: Chrysopidae), brown lacewings (Neuroptera: Hemerobiidae), hover flies (Diptera: Syrphidae), spined soldier bug and other stink bugs (Hemiptera: Pentatomidae), and spiders (Araneida) were monitored at 7–14 day intervals during the growing season for three years. Aboveground biomass production and nitrogen content of the legumes was measured for two years. Aphids peaked during early spring each year, with the highest density usually on ‘Dixie’ crimson clover and ‘Kenland’ red clover. Density of lady beetles was positively correlated with that of aphids, but spider densities were not. Other arthropods usually were not abundant. Nitrogen in the tops of the annual legumes ranged from 20 kg/ha to 89 kg/ha when assessed after a single harvest at anthesis; for the perennial legumes it was from 108 kg/ha to 179 kg/ha following two harvests in June and September. We chose two annual legumes (‘Dixie’ crimson clover and hairy vetch) and two perennial legumes (‘Louisiana S-1’ white clover and ‘Kenland’ red clover) for further evaluation.
ZnSe epitaxial films have been grown on (100) GaAs by reduced pressure organometallic chemical vapor deposition (OMCVD) from tertiary-butyl(allyl)selenium (tBASe) and dimethylzinc triethylamine adduct (DMZnNEt3) at temperatures of 325-450ΰC. Good surface morphology, film crystallinity and interface quality have been found with scanning electron microscopy (SEM), double crystal X-ray diffraction (DCD) and Rutherford back scattering spectroscopy (RBS). Secondary ion mass spectrometry (SIMS) shows negligible carbon concentration (below 5x1017atoms/cm3). Low temperature photoluminescence (PL) exhibits a strong near band-edge emission with a dominant donor-bound peak. Gas-phase pyrolysis of tBASe has been probed at reduced pressure in a molecular beam mass spectrometric system in hydrogen and deuterium carrier gases. The precursor decomposes above 200ΰC by β-hydrogen elimination and by homolysis of the Se-C bonds. High isobutene vs. isobutane ratios (50-100) indicate a predominance of β-hydrogen elimination over homolysis at temperatures below 400ΰC. Diallylselenium is present in the gasphase in low concentrations at temperatures of 200-350ΰC. Diallylselenium, methylallylselenium and dimethyl-selenium have been observed as minor by-products during pyrolysis of co-dosed tBASe and DMZnNEt3. The effect of the retro-ene decomposition pathway of allylselenium reagents on carbon incorporation into ZnSe films is further probed by growth experiments with in situ generated 2-methylpropaneselenal.
The lattice relaxation of strained Si1-xGex layers on Si (001) substrates has been examined. Single layers having a nominal composition of x = 0.14 were grown by Molecular Beam Epitaxy to thicknesses of 0.5, 1.0 and 1.5 μm, all of which are greater than the critical thickness where misfit-dislocation generation commences. Double-crystal and white-radiation topographic methods were used to reveal the misfit dislocation structure and distribution. The misfit dislocations were shown to extend from heterogeneous nucleation sites along the four available <110> directions in the plane of the interface. A symmetric distribution of dislocations between the orthogonal < 110> directions was observed. Secondary branching of the misfit dislocations was also observed which accelerates the relaxation process.